All
Suppliers
Products
CAD Models
Diverse Suppliers
Insights
By Category, Company or Brand
All Regions
Alabama
Alaska
Alberta
Arizona
Arkansas
British Columbia
California - Northern
California - Southern
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Manitoba
Maryland
Massachusetts - Eastern
Massachusetts - Western
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Brunswick
New Hampshire
New Jersey - Northern
New Jersey - Southern
New Mexico
New York - Metro
New York - Upstate
Newfoundland & Labrador
North Carolina
North Dakota
Northwest Territories
Nova Scotia
Nunavut
Ohio - Northern
Ohio - Southern
Oklahoma
Ontario
Oregon
Pennsylvania - Eastern
Pennsylvania - Western
Prince Edward Island
Puerto Rico
Quebec
Rhode Island
Saskatchewan
South Carolina
South Dakota
Tennessee
Texas - North
Texas - South
Utah
Vermont
Virgin Islands
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Yukon

First Steps Taken on 1.8M Square-Foot Expansion

Jeff Reinke
1/27/2019 | 5 min read
Subscribe
First Steps Taken on 1.8M Square-Foot Expansion

CSL Behring, a leading provider of medications for treating hemophilia and other biopharmaceutical therapies, recently initiated plans for an expansion that could total 1.8 million square feet in Kankakee, Illinois. The new facility will reside on 74 acres of recently acquired property and could take as long as 12 years to complete. The land cost alone was $17 million.

Exact investment numbers, in terms of cost and jobs created, are not yet known. However, the company is wrapping up work on a 300,000 square-foot, seven-story manufacturing structure that cost an estimated $240 million. The current site, which has been in place for more than 60 years, employs more than 1,400 workers.

The expansion stems from an increasing need for the company’s current medications, as well as for new treatments being developed for blood loss and burns. In addition to new structures emanating from the current site, buildings included in the land purchase will also be retrofitted.

Although the company would like to move quicker, regulatory requirements attached to equipment and facilities associated with pharmaceutical production need approval from the Food and Drug Administration (FDA), as well as from other regulatory agencies. These approvals will contribute significantly to the project’s timeline and end cost.

Next Up in Industry Trends
BMW 5 Series Earns World Luxury Car 2024 Title
Show More in Industry Trends